This Thursday, the key question is whether the ECB's decision can continue to support the DAX, especially after U.S. markets expressed some disappointment yesterday over the Federal Reserve's inaction. The Fed merely stated that it is prepared to intervene should such action become necessary.
U.S. markets reacted with selloffs, which also caused the DAX to dip slightly after the close of trading. However, for the morning session, the German benchmark index is expected to open around Wednesday’s closing level. In the afternoon, all eyes will be on the ECB’s interest rate decision. Markets expect the ECB to lower rates further, which could play into the hands of investors and support the DAX. As a result, the index may continue to gain ground and extend its Easter rally.
Sartorius Rallies on Strong Biotech Business
Among individual stocks, Sartorius stood out yesterday with a gain of 10.2%, followed by Commerzbank shares, which rose by 2.1%, and E.ON AG with a 1.9% increase. E.ON continues to confirm its upward trend, while Sartorius is still in the process of building a base. The strong performance in recent days is largely due to the success of the company’s biotechnology division.
Euro Holds Steady Above 1.13 USD
On Wednesday, the euro once again managed to hold above the 1.13 US dollar level and remains in the spotlight ahead of the ECB’s rate decision in the afternoon. A further rate cut seems to have already been priced in by the markets, which could allow the euro’s upward trend to continue. Nonetheless, a short-term correction remains a possibility. The ongoing trade tensions in the U.S. are likely to continue influencing the markets and may also provide additional support for the euro.
The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and as such is to be considered to be a marketing communication.
All information has been prepared by ActivTrades (“AT”). The information does not contain a record of AT’s prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information.
Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance is not a reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk.